Blake Atlantic publishes 2025 Annual Review
Group revenue, division performance and capital allocation for the year ended 31 December 2025.
Newsroom
We report candidly and consistently. Corporate disclosures and division news are published here.
Latest
Group revenue, division performance and capital allocation for the year ended 31 December 2025.
Atlantic Diagnostics Group adds 14 sites, extending patient access across underserved markets.
A 1.1 million sq ft addition to the group's directly held real estate portfolio.
Long-duration financing supporting a multi-year modernisation programme.
Strengthening oversight consistent with public-company standards.
Reporting on governance, workforce and environmental performance across all divisions.
Investors
2025 Annual Review
PDF · 4.2 MB
2025 Responsible Ownership Report
PDF · 2.8 MB
2024 Annual Review
PDF · 3.9 MB
Get in touch
For interviews, data requests or report archives, contact our communications team.